OA 14.06 Entrectinib in Patients with Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)

Autor: Ahn, M., Cho, B.C., Siena, S., Drilon, A., De Braud, F., Krebs, M., John, T., Karapetis, C., Johnson, A., Chow-Maneval, E., Multani, P., Doebele, R.
Zdroj: In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S1783-S1783
Databáze: ScienceDirect